Whitehawk Therapeutics (WHWK) Receivables (2016 - 2024)
Whitehawk Therapeutics (WHWK) reported Receivables of $5.9 million for Q4 2024, up 7.56% year-over-year from $5.5 million in Q1 2024, and down 9.74% quarter-over-quarter from $6.5 million in Q3 2024.
Whitehawk Therapeutics (WHWK) Receivables (2016 - 2024) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 6 years of Receivables data on file, last reported at $5.9 million in Q4 2024.
- Receivables for Q4 2024 came in at $5.9 million, up 7.56% year-over-year; the trailing twelve-month figure through Dec 2024 was $5.9 million (up 7.56% YoY), and the FY2024 annual result was $5.9 million, up 7.56% from the prior year.
- Receivables slipped to $5.9 million in Q4 2024 per WHWK's latest filing, from $6.5 million in the prior quarter.
- Over five years, Receivables peaked at $14.1 million in Q4 2020 and troughed at $1.9 million in Q4 2022.
- A 4-year average of $5.1 million and a median of $5.5 million in 2023 frame the typical range for Receivables.
- The sharpest annual moves came in 2023 and 2024: Receivables soared 194.74% in 2023, then fell 11.36% in 2024.
- A 4-year view of Receivables shows it stood at $14.1 million in 2020, then plunged by 86.84% to $1.9 million in 2022, then soared by 194.74% to $5.5 million in 2023, then gained by 7.56% to $5.9 million in 2024.
- Business Quant data shows WHWK's Receivables at $5.9 million in Q4 2024, $6.5 million in Q3 2024, and $5.9 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 5.90 Mn |
| Sep 30, 2024 | 6.54 Mn |
| Jun 30, 2024 | 5.92 Mn |
| Mar 31, 2024 | 4.93 Mn |
| Dec 31, 2023 | 5.49 Mn |
| Sep 30, 2023 | 5.72 Mn |
| Jun 30, 2023 | 3.68 Mn |
| Mar 31, 2023 | 5.57 Mn |
| Dec 31, 2022 | 1.86 Mn |
| Sep 30, 2022 | 2.26 Mn |
| Jun 30, 2022 | 2.06 Mn |
| Mar 31, 2022 | 2.71 Mn |
| Dec 31, 2020 | 14.15 Mn |
| Sep 30, 2017 | 39,246.00 |
| Jun 30, 2017 | 4,264.00 |
| Mar 31, 2017 | 32,453.00 |
| Dec 31, 2016 | 4,157.00 |